The Einstein Center for Epigenomics Signs Site License Agreement with CLC bio
News Mar 03, 2009
The Einstein Center for Epigenomics at the Albert Einstein College of Medicine in Bronx, New York, has entered into an agreement with CLC bio to put the company's full suite of bioinformatics tools into the hands of epigenomics researchers and other investigators at the College.
The suite includes CLC bio’s solutions for handling high-throughput sequencing data, CLC Genomics Workbench and CLC Genomics Server.
Dr. John Greally, director of the Einstein Center for Epigenomics, is enthusiastic about the multi-year partnership, noting, "CLC bio's tools are going to put sophisticated analytical ability into the hands of molecular biologists at Einstein, and will greatly enhance their ability to explore the massively-parallel sequencing data that we are generating. We see this as a way of lowering barriers for scientists who have not previously performed these high-throughput epigenomic assays, allowing them to explore their data and explore hypotheses."
CEO at CLC bio USA, Jan Lomholdt, comments, "We’re very happy to announce this site license agreement and look forward to working with and getting valuable feedback from world-renowned scientists at Einstein. This agreement is yet another stamp of approval by the scientific community in North America, where CLC bio is currently getting a strong foothold. We will be announcing more exciting agreements in the near future."
Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant BacteriaNews
A widely-used and twenty-year-old medicine used to treat multiple sclerosis can also beat a type of multi-resistant bacteria for which there are currently only a few effective drugs.READ MORE
Novel Chemistry Technique Simplifies Late-Stage Modification of Drug CompoundsNews
Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.READ MORE
Revolutionary Imaging Technique Uses CRISPR to Map DNA MutationsNews
The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.READ MORE
Comments | 0 ADD COMMENT
3rd Annual NGS Data Analysis and Informatics Conference
Feb 08 - Feb 09, 2018
3rd Annual Genome Editing & Engineering Conference
Feb 08 - Feb 09, 2018